Skip to main content
Top
Published in: BMC Health Services Research 1/2013

Open Access 01-12-2013 | Research article

Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study

Authors: Deliwe Nkosi, Saskia Janssen, Xavier Padanilam, Rianna Louw, Colin N Menezes, Martin P Grobusch

Published in: BMC Health Services Research | Issue 1/2013

Login to get access

Abstract

Background

Sizwe Tropical Diseases Hospital is the only specialized Hospital for the management of multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB cases in Gauteng Province. In South Africa, there is a mismatch between numbers of individuals with a laboratory diagnosis of drug-resistant tuberculosis (TB) and those being referred for the initiation of specialist treatment. We determined reasons for non-referral of MDR-TB and XDR-TB cases.

Methods

We conducted a descriptive questionnaire-based study amongst provincial primary health care facilities (PHC) and hospitals providing routine care for (drug-susceptible) TB, regarding specialist care referral of patients whose TB culture and susceptibility testing confirmed MDR-TB or XDR-TB diagnoses in the first half of 2008.

Results

In total 148 cases were analyzed; 144/148 (97%) had MDR-TB and 4/148 (3%) had XDR-TB. The main reason for non-referral to specialist care was loss to follow up, for patients diagnosed in-hospital (74/97; 76%) as well as in PHCs (11/21; 52%). Nineteen per cent (18/97) of patients diagnosed in hospital versus 33% (7/21) of patients diagnosed in PHCs deceased before referral.

Conclusions

A significant problem in the fight to control DR-TB is follow-up after diagnosis with a delay in patient tracing. TB Focal Points in hospital need to be strengthened in order to improve on patient follow-up and care, and tracer teams should assist with community follow up.
Literature
1.
go back to reference WHO Report M/XDR TB: Multi-drug and extensively drug-resistant tuberculosis - 2010 Global report on surveillance and response. 2010, Geneva: World Health Organization WHO Report M/XDR TB: Multi-drug and extensively drug-resistant tuberculosis - 2010 Global report on surveillance and response. 2010, Geneva: World Health Organization
2.
go back to reference World Health Organization: The Global Plan to Stop TB 2011-2015. 2011, Geneva: World Health Organization World Health Organization: The Global Plan to Stop TB 2011-2015. 2011, Geneva: World Health Organization
3.
go back to reference Baltussen R, Floyd K, Dye C: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005, 331: 1364-10.1136/bmj.38645.660093.68.CrossRefPubMedPubMedCentral Baltussen R, Floyd K, Dye C: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ. 2005, 331: 1364-10.1136/bmj.38645.660093.68.CrossRefPubMedPubMedCentral
4.
go back to reference Resch SC, Salomon JA, Murray M, Weinstein MC: Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med. 2006, 3: e241-10.1371/journal.pmed.0030241.CrossRefPubMedPubMedCentral Resch SC, Salomon JA, Murray M, Weinstein MC: Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med. 2006, 3: e241-10.1371/journal.pmed.0030241.CrossRefPubMedPubMedCentral
5.
go back to reference Farah MG, Rygh JH, Steen TW, Selmer R, Heldal E, Bjune G: Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis. 2006, 6: 33-10.1186/1471-2334-6-33.CrossRefPubMedPubMedCentral Farah MG, Rygh JH, Steen TW, Selmer R, Heldal E, Bjune G: Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis. 2006, 6: 33-10.1186/1471-2334-6-33.CrossRefPubMedPubMedCentral
6.
go back to reference Yimer S, Bjune G, Alene G: Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005, 5: 112-10.1186/1471-2334-5-112.CrossRefPubMedPubMedCentral Yimer S, Bjune G, Alene G: Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005, 5: 112-10.1186/1471-2334-5-112.CrossRefPubMedPubMedCentral
7.
go back to reference John MA, Menezes CN, Chita G, Sanne I, Grobusch MP: High tuberculosis and HIV coinfection rate, Johannesburg. Emerg Infect Dis. 2007, 13: 795-796. 10.3201/eid1305.060908.CrossRefPubMedPubMedCentral John MA, Menezes CN, Chita G, Sanne I, Grobusch MP: High tuberculosis and HIV coinfection rate, Johannesburg. Emerg Infect Dis. 2007, 13: 795-796. 10.3201/eid1305.060908.CrossRefPubMedPubMedCentral
8.
go back to reference Abdool Karim SS, Churchyard GJ, Abdool KQ, Lawn SD: HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009, 374: 921-933. 10.1016/S0140-6736(09)60916-8.CrossRefPubMedPubMedCentral Abdool Karim SS, Churchyard GJ, Abdool KQ, Lawn SD: HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009, 374: 921-933. 10.1016/S0140-6736(09)60916-8.CrossRefPubMedPubMedCentral
9.
go back to reference The South African National Tuberculosis Control Programme: Practical Guidelines. 2004 The South African National Tuberculosis Control Programme: Practical Guidelines. 2004
10.
go back to reference Grobusch MP: Drug-resistant and extensively drug-resistant tuberculosis in southern Africa. Curr Opin Pulm Med. 2010, 16: 180-185.PubMed Grobusch MP: Drug-resistant and extensively drug-resistant tuberculosis in southern Africa. Curr Opin Pulm Med. 2010, 16: 180-185.PubMed
11.
go back to reference Weyer K: DOTS-Plus for standardised management of multi-drug resistant tuberculosis in South Africa - Policy Guidelines. 2004, Pretoria: Medical Research Council Weyer K: DOTS-Plus for standardised management of multi-drug resistant tuberculosis in South Africa - Policy Guidelines. 2004, Pretoria: Medical Research Council
12.
go back to reference World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. 2011, Geneva: World Health Organization World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. 2011, Geneva: World Health Organization
13.
go back to reference Drobniewski F, Eltringham I, Graham C, Magee JG, Smith EG, Watt B: A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax. 2002, 57: 810-816. 10.1136/thorax.57.9.810.CrossRefPubMedPubMedCentral Drobniewski F, Eltringham I, Graham C, Magee JG, Smith EG, Watt B: A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax. 2002, 57: 810-816. 10.1136/thorax.57.9.810.CrossRefPubMedPubMedCentral
14.
go back to reference Donald PR, van Helden PD: The global burden of tuberculosis–combating drug resistance in difficult times. N Engl J Med. 2009, 360: 2393-2395. 10.1056/NEJMp0903806.CrossRefPubMed Donald PR, van Helden PD: The global burden of tuberculosis–combating drug resistance in difficult times. N Engl J Med. 2009, 360: 2393-2395. 10.1056/NEJMp0903806.CrossRefPubMed
Metadata
Title
Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study
Authors
Deliwe Nkosi
Saskia Janssen
Xavier Padanilam
Rianna Louw
Colin N Menezes
Martin P Grobusch
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2013
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-13-268

Other articles of this Issue 1/2013

BMC Health Services Research 1/2013 Go to the issue